⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Scantox Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Scantox Group
↗Lille Skensved, Denmark
Scantox is a leading European GLP-accredited contract research organization (CRO) specializing in preclinical services. Founded in 1977 and headquartered in Denmark, the company provides a comprehensive suite of services including drug discovery, regulatory toxicology, genetic toxicology, and pharmaceutical development/analytical services to global pharmaceutical, biotech, and medical device companies.
Since its acquisition by the Nordic investment firm Impilo in 2021, Scantox has pursued an aggressive growth strategy, expanding its capabilities and geographic footprint through multiple add-on acquisitions, including QPS Neuro (Austria) and Gentronix (UK). The company operates across Denmark, Sweden, Austria, and the UK, supporting clients from early discovery through to clinical trial phases.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:1977
Ownership:subsidiary
Status:operating
FUNDING
Investors:Impilo
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Impilo
Acquired By:Impilo (2021-01-01)
Subsidiaries:Scantox Neuro (formerly QPS Neuro), Gentronix, Q&Q Labs
Key Partnerships:Biopharmaceutical SMEs and global pharma companies
COMPETITION
Position:Leader
Competitors:Charles River Laboratories, Eurofins, Labcorp, WuXi AppTec
LEADERSHIP
Key Executives:
Jeanet Løgsted - CEO
Martin Amtoft - CFO
Andy Brown - Group Chief Commercial Officer
Board Members:Jens Bager, Nicholas Hooge, Daniel Spasic, Mette K. Agger, Mark Treherne
LINKS
Website:scantox.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Scantox Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.